ArticleAmerican journal of preventive cardiology2026
Association of cardiovascular risk scores with coronary plaque and its progression among individuals with family history of coronary artery disease.
Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Coronary artery calcium should be the complement to and not the end result of clinical risk scores.American journal of preventive cardiology · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multiple cardiovascular (CV) risk assessment scores can predict CV events. The current trend towards assessing atheroma has led to these scores being used to identify patients who might benefit from coronary plaque imaging. However, their association with plaque burden and progression is unclear. This study aimed to evaluate the relationship between CV risk scores, coronary plaque burden and its evolution. Methods: Asymptomatic, intermediate-risk individuals aged 40-70 years with a family history of CAD and not on statin therapy were recruited from 7 hospitals across Australia and multiple baseline CV risk scores were calculated. Participants with coronary artery calcium score (CACS) between 1-400 underwent coronary angiography, which was repeated 3 years post-baseline. Results: Of 1,060 participants (mean age 56±7 years, 54% female) who underwent CACS, 499 (44%) had CACS>0. Subsequently, 365 completed baseline and follow-up coronary angiography. The PREDICT 5-year risk score had the strongest, albeit weak, correlation (R Conclusion: At best, there were only weak associations between conventional risk scores and plaque burden, and plaque progression. These findings highlight the limitations of current risk tools for predicting plaque burden and the need for a new screening approach, whether universal CACS screening or integration of emerging biomarkers, to better identify individuals who would benefit from early preventive interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.